XML 65 R56.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Supplemental Balance Sheet Information Related to Operating and Financing Leases (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Lessee, Lease, Description [Line Items]      
Right-of-use assets, net [1] $ 4,036 $ 3,499  
Machinery and equipment, net 1,891 $ 2,088  
Total financing lease liabilities 60    
Operating and Financing Leases [Member]      
Lessee, Lease, Description [Line Items]      
Right-of-use assets, net 1,855   $ 2,343
Right-of-use lease liabilities, current 677   728
Right-of-use lease liabilities, noncurrent 2,398   3,075
Total operating lease liabilities 3,075   3,803
Machinery and equipment 536   537
Accumulated depreciation (500)   (391)
Machinery and equipment, net 36   146
Current liabilities 60   110
Noncurrent liabilities   60
Total financing lease liabilities $ 60   $ 170
Weighted average remaining lease term, Operating lease 4 years 1 month 6 days   4 years 10 months 24 days
Weighted average remaining lease term, Financing lease 6 months   1 year 6 months
Operating lease 11.28%   11.20%
Financing lease 11.55%   11.55%
[1] Oncocyte recorded certain right-of-use assets and liabilities for operating leases in accordance with ASC 842 (see Note 10).